Gruss & Co’s iShares Biotechnology ETF IBB Stock Holding History

Gruss & Co’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-7,500	Closed	-$846K	–	41
2015 Q4	$846K	Hold	7,500	–	–	1.13%	27
2015 Q3	$758K	Sell	7,500 -9,000	-55%	-$1.08M	1.19%	20
2015 Q2	$2.03M	Buy	+16,500	New	+$1.98M	1.77%	21

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Gruss & Co's IBB Position: Q1 2016 in Review

Gruss & Co sold out of iShares Biotechnology ETF (IBB) in Q1 2016, closing a stake of 7,500 shares — an estimated $846K sold.

Gruss & Co first reported a position in IBB in Q2 2015 and held it in 3 quarters. The position peaked at $2.03M in Q2 2015. 414 funds tracked by Wall St. Rank hold IBB as of Q1 2016.

Gruss & Co reported no remaining iShares Biotechnology ETF position as of Q1 2016 after selling out during the quarter.
Gruss & Co sold 7,500 iShares Biotechnology ETF shares in Q1 2016, an estimated $846K.
Gruss & Co first reported a position in iShares Biotechnology ETF in Q2 2015 and held it in 3 quarters.
Gruss & Co's iShares Biotechnology ETF position peaked at $2.03M in Q2 2015.
414 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2016.

Based on Gruss & Co's 13F filing for Q1 2016, filed 13 May 2016.